MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholde... (ct under the False Claims Act 31 U.S.C. ...)

MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits

Date:12/3/2008

ct under the False Claims Act, 31 U.S.C. S.S. 3729-3733; the Program Fraud Civil Remedies Act 31 U.S.C. S.S. 3801-3812; or the common law theories of breach of contract, payment by mistake, unjust enrichment and fraud. In addition, each of the qui tam relators releases MedQuist and its representatives from any civil or administrative money claim the United States has or may have for the Covered Conduct under the False Claims Act, 31 U.S.C. S.S.3729-3733.

The Company has not admitted nor or will it admit to liability or any wrongdoing in connection with the settlement.

Dismissal of the Newcastle and Kahn shareholder lawsuits.

Kahn Lawsuit

The Company has also announced the dismissal with prejudice of a shareholder putative class action lawsuit filed in the Superior Court of New Jersey, Chancery Division, Burlington County. As previously announced, the suit, Alan R. Kahn v. Stephen H. Rusckowski, et al.,

Docket No. BUR-C-7-08, was filed on January 22, 2008 by MedQuist shareholder Alan R. Kahn against the Company, Koninklijke Philips Electronics N.V. ("Philips") and four of MedQuist's former non-independent directors, Clement Revetti, Jr., Stephen H. Rusckowski, Gregory M. Sebasky and Scott Weisenhoff. Plaintiff purported to bring the action on his own behalf and on behalf of all current holders of MedQuist common stock. The complaint alleged that defendants breached their fiduciary duties of good faith, fair dealing, loyalty, and due care by purportedly agreeing to and initiating a process for a sale of the Company or a change of control transaction which would allegedly cause harm to plaintiff and the putative class. Plaintiff sought both monetary and injunctive relief.

On June 12, 2008, following Philips' announcement that it was selling its approximately 69.5% interest in MedQuist to CBaySystems Holdings Limited, p
'/>"/>

0

GOOD

Page: 1 2 3 4 5 6
Related medicine news :

1. New Jersey-Based MedQuist Pays U.S. $6.6 Million to Resolve False Claims Act Allegations
2. MedQuist and Primordial to Demonstrate Integrated Applications at RSNA
3. MedQuist and Clario Form Partnership to Integrate zVision Radiology Practice Management Software with SpeechQ for Radiology
4. MedQuist Introduces SpeechQ for Radiology Integrated with RadWorkFlow
5. MedQuist Reports Third Quarter 2008 Results
6. MedQuist Reports Second Quarter 2008 Results
7. MedQuist Announces Changes to Board of Directors
8. MedQuist Announces Declaration of $2.75 per share Dividend on Common Stock
9. Award-Winning Massachusetts Hospital Selects MedQuist Enterprise Technology for Clinical Documentation and Speech Recognition
10. MedQuist Announces Dismissal of South Broward Litigation and Appointment of New Interim President & CEO
11. MedQuist to Get New Majority Stakeholder

Post Your Comments:

MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholde...(ct under the False Claims Act 31 U.S.C. ...),Health